The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | A | Alimentary tract and metabolism | |
| 2 | A10 | Drugs used in diabetes | |
| 3 | A10B | Blood glucose lowering drugs, excl. insulins | |
| 4 | A10BD | Combinations of oral blood glucose lowering drugs | |
| 5 | A10BD23 | Metformin and ertugliflozin |
| Active Ingredient | Description | |
|---|---|---|
| Metformin and Ertugliflozin |
Combination of two anti-hyperglycaemic agents with complementary mechanisms of action to improve glycaemic control in patients with type 2 diabetes: ertugliflozin, a SGLT2 inhibitor, and metformin, a member of the biguanide class. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| SEGLUROMET Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
| STEGLUJAN Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
